Constellation Pharmaceut... Stock Price

0.00 (0.0%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Constellation Pharmaceuticals Inc CNST NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 35.62 07:00:00
Open Price Low Price High Price Close Price Prev Close
Bid Price Ask Price Spread News
35.70 37.00 1.30 - -
Trades Volume Avg Volume 52 Week Range
1 19 689,775 17.00 - 50.90
Last Trade Time Type Quantity Stock Price Currency
07:00:00 19 $ 35.61 USD

Constellation Pharmaceut... Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.69B 47.58M 32.53M $ - $ - -3.03 -12.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -4.02k 0.40%

more financials information »

Constellation Pharmaceut... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CNST Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week32.5339.3032.2635.72620,7713.099.5%
1 Month32.0639.3026.5031.07537,6153.5611.1%
3 Months19.6539.3019.310128.95633,32215.9781.27%
6 Months28.0139.3017.0025.50583,3387.6127.17%
1 Year35.6650.9017.0029.37543,076-0.04-0.11%
3 Years11.4859.48994.00528.68333,77124.14210.28%
5 Years11.4859.48994.00528.68333,77124.14210.28%

Constellation Pharmaceut... Description

Constellation Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance. The company's lead products include CPI-0610, which is a small molecule designed to promote anti-tumor activity by specifically inhibiting the function of BET proteins, which normally enhance target gene expression, and CPI-1205 which is a small molecule designed to promote anti-tumor activity by specifically inhibiting EZH2, an enzyme that suppresses target gene expression. It operates in the segment of the development of novel therapeutics in the field of epigenetics.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.